ismpp eu, 23–24 jan, 2018 poster session...
TRANSCRIPT
![Page 1: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/1.jpg)
ISMPP EU, 23–24 Jan, 2018Poster Session Summary
Hannah Mace MPharmacol, CMPP™Presented at a MedComms Networking event, 7 February 2018
![Page 2: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/2.jpg)
2
Disclosures
• Principal Medical Writer at Aspire Scientific Ltd
• One of the team at thepublicationplan.com
• Presented a poster at ISMPP EU 2018
![Page 3: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/3.jpg)
3
ISMPP EU 2018
![Page 4: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/4.jpg)
4
A record number of poster presentations
6 oral presentations*
27 posters
![Page 5: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/5.jpg)
5
A wealth of topics & research methods
![Page 6: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/6.jpg)
6
Some key themes
Getting research to the readers
Involving patients
Professional medical writers
Advancing the
profession
![Page 7: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/7.jpg)
7
Datatransparency1
• Generallyhavelessexperiencecollaboratingwithpatients,butareenthusiastictodoso
Getting the research to the readers: the good news
1. Baronikova et al. Disclosure of results of clinical trials sponsored by pharmaceutical companies.
• 75%ofindustry-sponsoreddatadisclosed(2006–2015)1
Step 1 – Clear, comprehensive & transparent reporting
![Page 8: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/8.jpg)
8
Methodologicalrigour
Reportingrigour• Consensus(Delphi)guidelinesinrarediseasesoftenomitted
keymethodologicaldetails2*
Getting the research to the readers: more to do
1. Booth et al. A day in the life of systematic reviews: adherence to PRISMA guidelines in a cross-section of systematic reviews from a single day in 2017.2. Resemann et al. Reporting of Delphi methods to achieve consensus on guidelines in rare diseases.*
• >50%ofsystematicreviewsdidnotfullymeetPRISMAcriteria1• Consensus(Delphi)guidelinesinrarediseasesoftenomitteda
systematicliteraturereview2*
BarrierstoaccessexistStep 1 – Clear, comprehensive & transparent reporting
![Page 9: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/9.jpg)
9
Openaccessextendsreach
• Generallyhavelessexperiencecollaboratingwithpatients,butareenthusiastictodoso
Getting the research to the readers: the good news
1. Bell et al. Does ‘open access’ affect the amount of attention an article receives online.* 2. Wiehn et al. Can the social-media footprint of published articles predict long-term impact?*
• Altmetricscoreswerehigherforopenaccessarticles1,2*
Journalarticlesareusedbypatients&caregivers1*Step 2 – Open access
![Page 10: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/10.jpg)
10
Barriersremainto‘true’openaccess
• Generallyhavelessexperiencecollaboratingwithpatients,butareenthusiastictodoso
Getting the research to the readers: more to do
1. Moss et al. Ease of online accessibility to expert disease management guidelines. 2. Ellison et al. Do journals restrict access to commercially funded research?
• 1/6ofguidelinesnotfreetoaccess1• Forthosethatwerefree,thiswasnotalwaysclear
onPubMed• 62%high-tierjournalsofferCC-BY;mostcharge$50002
• Veryfewforindustry-fundedresearch
Journalarticlesareusedbypatients&caregivers1*Step 2 – Open access
![Page 11: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/11.jpg)
11
Cross-stakeholderengagementcanbeeffective
Congressactivity• Simultaneouscongressactivitygeneratedextramediaand
socialmediacoverage2
Getting the research to the readers: the good news
1. Wiehn et al. Can the social-media footprint of published articles predict long-term impact?* 2. Shepherd et al. An exploratory analysis of online activity surrounding simultaneous publication and congress presentation.
• Publishertweetscanincreaseoverallnumberoftweets1*
BarrierstoaccessexistStep 3 – Extending reach through digital and social media
![Page 12: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/12.jpg)
12
Opportunitiesmissed
• Generallyhavelessexperiencecollaboratingwithpatients,butareenthusiastictodoso
Getting the research to the readers: more to do
1. Venn et al. Do authors fully utilize opportunities to share supplementary information at conferences?*
• Giventheopportunity,40%ofauthorsdidnotprovideane-poster,<3%shareanaudiofile1*
Journalarticlesareusedbypatients&caregivers1*Step 3 – Extending reach through digital and social media
![Page 13: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/13.jpg)
13
Journalarticlesareusefultopatients &caregivers1*
Publicationsprofessionalskeentocollaborate2
• Generallylessexperiencedcollaboratingwithpatients,butareenthusiastictodoso
Involving patients: the good news
1. Georgieva et al. Should we consider patients in communication plans?* 2. Lommelé & deSchoolmeester. Involving patients in research from an industry-sponsored registry.
• 51%thinktheyhelptheirclinicaldecision-making• 45%thinktheyaiddiscussionswithHCPs
• 45%accessjournalarticles
Journalarticlesarereadbypatients&caregivers1*
![Page 14: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/14.jpg)
14
Lackofinvolvementoracknowledgement3*
Patientsasauthors3*• 1articleincludedapatientasanauthor
Involving patients: more to do
1. Georgieva et al. Should we consider patients in communication plans?*2.Thurtle et al. Rare disease publications: How accessible are they?
3. Wadsworth et al. Patient involvement…or not? Analysis of “Patient Involvement” statements in clinical trial publications in The BMJ*.
• 25%ofclinicaltrialpublicationsdidnotinvolve,oreventhank,patients
• <20%involvedpatientsinstudydesignandconduct
• Jargon1*• Howconclusionsrelatetopatients1*• Only5%ofjournalspublishingrarediseasesrequiredlaysummary2
Barrierstoaccessexist
![Page 15: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/15.jpg)
15
“Ethical,accurateandtimely”1
• AMWA–EMWA–ISMPPJointPositionStatementontheroleofprofessionalmedicalwriters
Transparencyandquality2
• IncreasedcompliancewithCONSORTguidelinesandtransparentreportingoffinancialdisclosures
Valuedbyauthors• 78%ofcorrespondingauthorsfoundsupportuseful3• Non-English-speakingauthorsvaluesupport;some
barrierstoaccessexist4
The role of professional medical writers
1. Gertel et al. Development and communication of the AMWA–EMWA–ISMPP Joint Position Statement on the role of professional medical writers. 2. Evuarherhe et al. Association between professional medical writing support and the quality, ethics and timeliness of clinical trials reporting: a systematic review.
3. Clausi et al. Do corresponding authors value the support of professional medical writers? 4 Pons et al. Why don’t Spanish-speaking physicians publish more in English?
![Page 16: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/16.jpg)
16
Publishourfindings• ISMPPmembersdon’talwayspracticewhatwepreach:
only5%abstractsbecamefullpublications1
Reachingouttootherorganisations• AwarenesssurveyattheEighthInternationalCongress
onPeerReviewandScientificPublication2
Within-industrycommunication• Thecommunitycoulddomoretoengageonline3
Advancing the profession
1. Neuner-Jehle. Do we publish enough? Publication rates of ISMPP meeting abstracts.2. Woolley et al. Survey evidence to advance advocacy: Awareness of publication professional initiatives at the Peer Review Congress.
3. Mace et al. How do medical publication professionals engage with online news resources?
![Page 17: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/17.jpg)
17
Find out more
• Abstracts: published in April’s CMRO
• Posters: available to members at ismpp.org
• Medical publications news and ISMPP EU 2018 meeting reports: www.thepublicationplan.com
![Page 18: ISMPP EU, 23–24 Jan, 2018 Poster Session Summarymedcommsnetworking.com/presentations/mace_070218.pdf · 1. Venn et al. Do authors fully utilize opportunities to share supplementary](https://reader034.vdocument.in/reader034/viewer/2022050505/5f9723c9c0c22c0a9c43181f/html5/thumbnails/18.jpg)
18
For written reports on the ISMPP EU meeting see: ThePublicationPlan.com
For written reports on the ISMPP EU meeting see: ThePublicationPlan.com
Speed research: Part 2• Reporting Delphi Methods to achieve consensus on guidelines in rare
diseases• Should we consider patients in communication plans?• Patient involvement… or not? Analysis of ‘patient involvement’ statements in
clinical trial publications in the BMJ
Thank you